According to market observers, shares of the company are available at a premium of ₹18 in the grey market today

Today is the third and last day for the initial public offering (IPO) of contract research, development, and manufacturing organization Sai Life Sciences which was opened on Wednesday, December 11. In the grey market,

Sai Life Sciences Ltd.'s initial public offering entered its final day for subscription on Friday. It was subscribed 1.65 times, as of 11:45 a.m. The company aims to raise Rs 3,042 crore via the offering. On the first day, the IPO was subscribed 0.84 times or 84% and it was booked 1.25 times on the second day.

Sai Life Sciences IPO price band is fixed at ₹522 to ₹549 per share. At the upper-end of the price band, the company plans to raise ₹3,042.62 crore from the public issue.

The Sai Life Sciences IPO is a combination of fresh issuance of Rs 950 crore worth of shares and an offer-for-sale of 3.81 crore shares worth Rs 2,092.6 crore

Sai Life Sciences Ltd's Rs 3,043-crore IPO saw a remarkable 10.26 times subscription on the final day. The company's shares received bids far surpassing the 3.88 crore shares available, with significant interest from institutional and individual investors.

The Sai Life Sciences IPO, priced between ₹522 to ₹549 opened for subscription on December 11. The IPO combines the new issuance of equity shares of about ₹950 crore and an offer for sale (OFS) of up to 3.

TPG Capital-backed Sai Life Sciences IPO closes with 1.25x subscription, offering fresh issue and stake sale. Market lot: 27 shares.

Sai Life Sciences Ltd.'s initial public offering entered the second day on Thursday. It was subscribed 0.89 times or 89% as of 11:06 a.m. The company aims to raise Rs 3,042 crore via the offering.

The unlisted shares of Sai Life Sciences were trading at Rs 586 apiece, reflecting a grey market premium (GMP) of Rs 37 or 6.74 per cent per share over the upper end of the IPO price band of Rs 549